Health Professional Information

Nausea and vomiting of pregnancy (NVP) is the most common medical condition in pregnancy, affecting an estimated 80% of all pregnant women. Since each woman and each pregnancy is different, the severity and the managment of NVP will vary from woman to woman.

This section is meant to provide information to health professionals. It provides information on the management of NVP as recommended in the SOGC Clinical Practice Guidelines and the Motherisk Treatment Algorithm.

This section also provides comprehensive information about Diclectin®, the only pharmacological solution, specifically indicated, prescribed and labelled for the management of NVP. Diclectin® consists of a combination of 10 mg of doxylamine succinate and 10 mg of pyridoxine hydrochloride (vitamin B₆) in a delayed-released formulation. This combination has been prescribed for over 50 years to more than 33 million pregnant women.

Diclectin® is a prescription medication available only in Canada.